Cardinal Health Inc. buy UBS Group AG
Start price
05.02.24
/
50%
€96.44
Target price
05.02.25
€116.35
Performance (%)
0.50%
Price
26.04.24
€96.46
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Cardinal Health Inc. is nearly unchanged. A total of €0.46 was paid as dividends for this prediction. This prediction currently runs until 05.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cardinal Health Inc. | -0.145% | -0.145% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by UBS_Group_AG for this prediction
In the thread Cardinal Health Inc. diskutieren
Cardinal Health, Inc. (NYSE: CAH) had its price target raised by analysts at UBS Group AG from $122.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for CAH provided by MarketBeat
Stopped prediction by UBS_Group_AG for Cardinal Health Inc.
Cardinal Health Inc.
Start price
Target price
Perf. (%)
€98.14
29.01.24
29.01.24
€112.87
29.01.25
29.01.25
-1.24%
26.04.24
26.04.24
